Neuroscience Letters
September 1, 1980
O G Berge, K Hole, H Dahle
34 citations
The effects on pain sensitivity of intracerebroventricular injections of 5-methoxy-N,N-dimethyltryptamine were tested by the tail-flick method. Following administration of 1.6, 3.1, 6.3, 12.5 and 25 micrograms (n = 8 for each dose), tail-flick latencies were reduced by 13-24%. Fifty and 100 micrograms caused a biphasic response (hyperalgesia followed by analgesia), whereas 400 micrograms...
British Journal of Pharmacology
May 1, 1980
P. Jenner, C.d. Marsden, C.m. Thanki
38 citations
N,N‐Dimethyltryptamine (DMT) in pargyline pretreated rodents induced a dose‐dependent behavioural syndrome consisting of hyperactivity, prostration and hindlimb abduction, mild tremor, Straub tail, retropulsion and jerking. In rats pretreated with pargyline, the behavioural syndrome induced by DMT differed from that induced by l‐tryptophan or quipazine, in the lack of forepaw treading and...
Psychopharmacology
1980
M Davis, D I Astrachan, P M Gendelman et al.
39 citations
The effects of different doses (0.03, 0.06, 0.12, 0.25, 1.0, 2.0, 4.0, and 8.0 mg/kg body weight) of 5-methoxy-N,N-dimethyltryptamine (5-MeODMT) were tested on the acoustic startle reflex in rats. Beginning at 0.12 mg/kg, 5-MeODMT increased startle monotonically up to the highest dose used. 5-MeODMT still increased startle in acutely decerebrate rats or when infused directly onto the spinal...
European Journal of Pharmacology
October 15, 1979
Miljana Simonovic, Herbert Y. Meltzer
11 citations
Repeated administration of 5-methoxy-N,N-dimethyltryptamine (5MeODMT, 5 mg/kg, a serotonin agonist, every 3 h for a total of 4 injections) potentiated its prolactin (PRL)-releasing effect and that of two other serotonin agonists, quipazine and N,N-dimethyltryptamine. This pretreatment schedule had no effect on PRL response to anti-dopaminergic drugs. The onset of enhanced PRL response to...
Archives of General Psychiatry
June 1979
R M Murray, M C Oon, R Rodnight et al.
The excretion of the hallucinogen dimethyltryptamine (DMT) and its precursor N-methyltryptamine (NMT) was studied among 74 recently admitted psychiatric patients and 19 normal persons. Both compounds were detected in 24-hour urine samples from all subjects. Dimethyltryptamine excretion was greatest in schizophrenia, mania, and "other psychosis" and tended to decline as clinical state improved....
Psychopharmacology
April 25, 1979
D Ruffing, B Kovacic, S Demetriou et al.
The narcotic antagonist naloxone was tested to determine its possible interaction with N,N-dimethyltryptamine (DMT) and lysergic acid diethylamide-25 (LSD) in adult male Holtzman rats trained to press a bar on a fixed-ratio four schedule (FR4), i.e., every fourth press earned a reward of 0.01 ml sugar sweetened milk. LSD (0.1 mg/kg) or increasing doses of DMT (1.0, 3.2, and 10.0 mg/kg) were...
Chemischer Informationsdienst
December 26, 1978
Richard A Glennon, Stephen M. Liebowitz, Elizabeth C. Mack
AbstractDie Phenalkylamine (I) und bzw. Tryptamine (II) werden auf pharmakologische Wirkung untersucht.
Journal of Neurochemistry
October 1, 1978
Giorgio Stramentinoli, Ross J. Baldessarini
Abstract In vivo conversion of intracisternally administered [14C]tryptamine to [14C]N,N‐dimethyl‐tryptamine (DMT) in rat brain, even in the presence of an excess of substrate and methyl donor appeared to be insignificant, although enzymatically synthesized [14C]DMT was recovered readily after intracranial injection. Authenticity of [14C]DMT was demonstrated by cocrystallization with authentic...
Pharmacology, Biochemistry, and Behavior
July 1, 1978
James K. Walters, Michael H. Sheard, Michael T. Davis
18 citations
Rats were tested for shock elicited fighting under various doses of N,N-dimethyltryptamine (0.12, 0.25, 0.50, 1.0, 4.0, 8.0 mg/kg) and 5-methoxy-N,N-dimethyltryptamine (0.06, 0.12, 0.5, 2.0 mg/kg). Both drugs produced an inhibition of fighting at higher doses but no significant effects at lower doses. The effects of these drugs on shock elicited fighting, as well as on other behaviors, thus...
Journal of Pharmacy and Pharmacology
April 1, 1978
J D Sinden, D M Atrens
J D Sinden, D M Atrens; 5-Methoxy-NN-dimethyltryptamine: differential modulation of the rewarding and aversive components of lateral hypothalamic self-stimulati